Accure Acne, Inc. announced the FDA had cleared their Accure Laser™ System for treating mild-to-severe inflammatory acne vulgaris.
Results from a nonrandomized clinical trial suggest that apremilast (Otezla), may have cardiometabolic health benefits for patients with psoriasis.
The FDA approved ellacor System uses micro-coring technology (MCT) to treat facial wrinkles and tightening.
South Beach Symposium has been a cornerstone in medical and aesthetic dermatologic education for 20 years.
Dermatologists have seen an increase of acne in adult females and ponder the best treatment options available for their patients.
A look at why dentists should consider adding facial aesthetic services to their services.
A recent study demonstrated that women with psoriatic arthritis (PsA) experience a higher disease burden than men.
National Retinol Day is November 7. Retinol is one of the most popular anti-aging skincare ingredients on the market today.
Tune in to Dr. Christopher Bunick’s SBS presentation as he discusses the risks posed by the human carcinogen, benzene.
Here are some ways you can help educate your patients on the importance of maintaining healthy skin.
LiVDerm is committed to providing relevant, industry-specific content for practitioners to enhance and grow their level of expertise.
Study reveals that systemic treatment of atopic dermatitis can lead to an increase in relief of symptoms and improved mood.
World Psoriasis Day is October 29th. This year’s theme looks beyond the skin and addresses the mental health implications.
Dr. Peter Lio provides insight into the use of topical corticosteroids in eczema.
Keeping on top of current trends, emerging therapies, and innovative technologies is vital to you and your practice.
A brief look at how millennial patients are helping to shape the face of dermatologic aesthetic education.
According to a recent Kaiser Family Foundation report, there are continued disparities in monkeypox cases among Black Americans.
Read a recap of LiVDerm’s recent Masters of Pediatric Dermatology Skin of Color Virtual Summit, presented by expert pediatric dermatologists.
An increase in atopic dermatitis research has led to an overall improved understanding of the condition.
Arcutis Biotherapeutics announces positive results of its pivotal phase three trial of roflumilast foam 0.3% for scalp and body psoriasis.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
